Methods for treating cancer using allogeneic lymphocytes without graft vs host disease activity
Patent Number: 6213127
Date of First Priority Issue: Tuesday September 1st, 1998
Date Issued: Tuesday April 10th, 2001
Assignee: Emory University (Atlanta, GA)
Inventor: Waller, Edmund K. (Atlanta, GA)
From Class: Use
Comments: No comments
This patent teaches ways of administering allogeneic lymphocytes that have been treated chemically or with radiation so as to elicit an antitumor effect while at the same time not causing graft versus host.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.